DK2112154T3 - Estre i position 20 af camptothecin - Google Patents

Estre i position 20 af camptothecin

Info

Publication number
DK2112154T3
DK2112154T3 DK09162737.2T DK09162737T DK2112154T3 DK 2112154 T3 DK2112154 T3 DK 2112154T3 DK 09162737 T DK09162737 T DK 09162737T DK 2112154 T3 DK2112154 T3 DK 2112154T3
Authority
DK
Denmark
Prior art keywords
camptothecin
esters
Prior art date
Application number
DK09162737.2T
Other languages
English (en)
Inventor
Mauro Marzi
Domenico Alloatti
Claudio Pisano
Maria Ornella Tinti
Loredana Vesci
Franco Zunino
Original Assignee
Sigma Tau Ind Farmaceuti
Ist Naz Stud Cura Dei Tumori
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti, Ist Naz Stud Cura Dei Tumori filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of DK2112154T3 publication Critical patent/DK2112154T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DK09162737.2T 2002-05-31 2003-05-28 Estre i position 20 af camptothecin DK2112154T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2002RM000306A ITRM20020306A1 (it) 2002-05-31 2002-05-31 Esteri in posizione 20 di camptotecine.
EP03730481A EP1509529B1 (en) 2002-05-31 2003-05-28 Esters in position 20 of camptothecins

Publications (1)

Publication Number Publication Date
DK2112154T3 true DK2112154T3 (da) 2013-10-21

Family

ID=11456339

Family Applications (2)

Application Number Title Priority Date Filing Date
DK09162737.2T DK2112154T3 (da) 2002-05-31 2003-05-28 Estre i position 20 af camptothecin
DK03730481T DK1509529T3 (da) 2002-05-31 2003-05-28 Estere på camptotheciners position 20

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK03730481T DK1509529T3 (da) 2002-05-31 2003-05-28 Estere på camptotheciners position 20

Country Status (22)

Country Link
US (2) US7452900B2 (da)
EP (2) EP1509529B1 (da)
JP (1) JP4593270B2 (da)
KR (1) KR101000963B1 (da)
CN (1) CN100376583C (da)
AR (1) AR040140A1 (da)
AT (1) ATE439362T1 (da)
AU (1) AU2003241161C1 (da)
CA (1) CA2487252C (da)
CY (2) CY1109581T1 (da)
DE (1) DE60328777D1 (da)
DK (2) DK2112154T3 (da)
ES (2) ES2432379T3 (da)
HK (1) HK1079206A1 (da)
IT (1) ITRM20020306A1 (da)
MX (1) MXPA04011681A (da)
PE (1) PE20040533A1 (da)
PL (1) PL374009A1 (da)
PT (2) PT1509529E (da)
SI (2) SI2112154T1 (da)
TW (1) TWI331151B (da)
WO (1) WO2003101996A2 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2852606A1 (fr) * 2003-03-18 2004-09-24 Inst Nat Sante Rech Med Moyens pour inhiber simultanement l'expression de plusieurs genes impliques dans une pathologie
JP5170741B2 (ja) 2004-04-27 2013-03-27 ウェルスタット バイオロジクス コーポレイション ウイルスおよびカンプトテシン類を使用する癌の処置
ITRM20040242A1 (it) * 2004-05-13 2004-08-13 Ist Naz Stud Cura Dei Tumori "7-t-butossiimminometilcamptotecina coniugata in posizione 20 con antagonisti delle integrine.
MX2007015407A (es) 2005-07-14 2008-02-19 Wellstat Biologics Corp Tratamiento del cancer utilizando virus, fluoropirimidinas y camptotecinas.
CN103864811A (zh) * 2012-12-13 2014-06-18 天津科技大学 一种新颖的10-羟基喜树碱20位衍生物制备方法及其在抗肿瘤药物中的应用
WO2014121033A1 (en) * 2013-02-04 2014-08-07 Fl Therapeutics Llc Soluble complexes of drug analogs and albumin
WO2015200837A1 (en) 2014-06-27 2015-12-30 Fl Therapeutics Llc Abiraterone derivatives and non-covalent complexes with albumin
US10201617B2 (en) 2014-10-24 2019-02-12 Zhuhai Beihai Biotech Co., Ltd. 3-substituted piperidine-2, 6-diones and non-covalent complexes with albumin
US10517961B2 (en) 2015-09-25 2019-12-31 ZY Therapeutics, Inc. Drug formulation based on particulates comprising polysaccharide-vitamin conjugate
CN106279286B (zh) * 2016-08-12 2018-11-30 华中科技大学 一种喜树碱膦酸酯类化合物、其制备方法及应用
CN110577551A (zh) * 2018-06-08 2019-12-17 遵义医学院 喜树碱-甘氨酸-5,6-二溴去甲斑蝥素结合物及其应用
PE20221005A1 (es) 2019-07-11 2022-06-15 Sun Pharma Advanced Res Co Ltd Derivados de la camptotecina
WO2022037704A1 (zh) * 2020-08-21 2022-02-24 诺茗(北京)生物医药有限公司 一种水溶性抗肿瘤前药及其药物组合物和用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4943579A (en) * 1987-10-06 1990-07-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Water soluble prodrugs of camptothecin
US5004758A (en) * 1987-12-01 1991-04-02 Smithkline Beecham Corporation Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells
JP3186166B2 (ja) * 1992-02-10 2001-07-11 ロンザ リミテッド サリチロイル−カルニチンおよびその製造方法
US5646159A (en) * 1994-07-20 1997-07-08 Research Triangle Institute Water-soluble esters of camptothecin compounds
JP3751025B2 (ja) 1995-12-15 2006-03-01 ザ デクスター コーポレイション 研摩性不織繊維ウェブ材料及びその製造方法
EP1100589B1 (en) 1998-07-30 2005-01-19 Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. Use of propionyl l-carnitine and acetyl l-carnitine in the preparation of medicaments with anticancer activity
US6204257B1 (en) 1998-08-07 2001-03-20 Universtiy Of Kansas Water soluble prodrugs of hindered alcohols
ATE216998T1 (de) * 1999-03-09 2002-05-15 Sigma Tau Ind Farmaceuti Camptothecin-derivate mit antitumor-wirkung
DE19916945C1 (de) 1999-04-15 2000-10-05 Clariant Gmbh Aromatische Aldehydharze und ihre Verwendung als Emulsionsspalter
US6228855B1 (en) 1999-08-03 2001-05-08 The Stehlin Foundation For Cancer Research Aromatic esters of camptothecins and methods to treat cancers
US6288072B1 (en) 1999-12-29 2001-09-11 Monroe E. Wall Camptothecin β-alanine esters with topoisomerase I inhibition
US6629995B1 (en) 2000-03-31 2003-10-07 Super Gen, Inc. Camptothecin conjugates

Also Published As

Publication number Publication date
EP2112154A1 (en) 2009-10-28
AU2003241161C1 (en) 2010-03-04
US20070213353A1 (en) 2007-09-13
KR101000963B1 (ko) 2010-12-13
CY1114692T1 (el) 2016-10-05
ATE439362T1 (de) 2009-08-15
AU2003241161B2 (en) 2009-10-22
EP1509529B1 (en) 2009-08-12
CA2487252A1 (en) 2003-12-11
DK1509529T3 (da) 2009-12-14
PL374009A1 (en) 2005-09-19
WO2003101996A3 (en) 2004-01-29
ITRM20020306A0 (it) 2002-05-31
ES2331569T3 (es) 2010-01-08
HK1079206A1 (en) 2006-03-31
TW200403246A (en) 2004-03-01
CA2487252C (en) 2010-08-10
PE20040533A1 (es) 2004-08-26
AU2003241161A1 (en) 2003-12-19
ES2432379T3 (es) 2013-12-03
US7498340B2 (en) 2009-03-03
WO2003101996A8 (en) 2004-04-29
WO2003101996A2 (en) 2003-12-11
AR040140A1 (es) 2005-03-16
DE60328777D1 (en) 2009-09-24
EP1509529A2 (en) 2005-03-02
SI2112154T1 (sl) 2013-12-31
US20050256148A1 (en) 2005-11-17
CN1656101A (zh) 2005-08-17
EP2112154B1 (en) 2013-07-24
PT1509529E (pt) 2009-11-13
PT2112154E (pt) 2013-10-02
SI1509529T1 (sl) 2009-12-31
ITRM20020306A1 (it) 2003-12-01
US7452900B2 (en) 2008-11-18
MXPA04011681A (es) 2005-03-31
KR20050036910A (ko) 2005-04-20
JP2005529935A (ja) 2005-10-06
CY1109581T1 (el) 2014-08-13
CN100376583C (zh) 2008-03-26
TWI331151B (en) 2010-10-01
JP4593270B2 (ja) 2010-12-08

Similar Documents

Publication Publication Date Title
FR18C1024I2 (fr) Derives d'heterocyclocarboxamide
NL350083I1 (nl) Thiencarbazone-methyl + mesosulfuron-methyl ester
DE10393374D2 (de) Zusammensetzung
SE0500163L (sv) Sammansättning
DK2112154T3 (da) Estre i position 20 af camptothecin
DK1492934T3 (da) Dørenhed
FR2835321B1 (fr) Monture d'objectif
DK1458413T3 (da) Farmaceutiske sammensætninger på b asis af azetidin-derivater
DK1475379T3 (da) Anvendelse af scopinesterderivater til fremstilling af lægemidler
DK1487778T3 (da) Substituerede 4 aminocyclohexanoler
DK1691814T3 (da) Antiinflammatoriske midler
FIU20020046U0 (fi) Ammesovitelma
FI20031302A0 (fi) Kärkiteline
ATE535775T1 (de) Präzisionsdendrometer
DE50214840D1 (de) Ethylestern
FR2887541B1 (fr) Compositions d'inertage d'impuretes
ATA5212002A (de) Teleskop
FR2852042B1 (fr) Piece d'aretier
FR2851859B1 (fr) Circuit d'interface
FR2852465B1 (fr) Generateur d'horloge
FR2866666B1 (fr) About d'echafaudage
NO20034826D0 (no) Bokholder'n
SE0101214D0 (sv) Oxetane-caprolactone ester
NO20033536D0 (no) Snus-porsjonerer
ITPT20030007U1 (it) "mybox"